Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling

Yasushi Hoshikawa, Norbert F. Voelkel, Tracy L. Gesell, Mark D. Moore, Kenneth G. Morris, Lori A. Alger, Shuh Narumiya, Mark W. Geraci

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Prostacyclin (PGI2) reduces pulmonary vascular resistance and attenuates vascular smooth muscle cell proliferation through signal transduction following ligand binding to its receptor. Because patients with severe pulmonary hypertension have a reduced PGI2 receptor (PGI-R) expression in the remodeled pulmonary arterial smooth muscle, we hypothesized that pulmonary vascular remodeling may be modified PGI-R dependently. To test this hypothesis, PGI-R knockout (KO) and wild-type (WT) mice were subjected to a simulated altitude of 17,000 ft or Denver altitude for 3 wk, and right ventricular pressure and lung histology were assessed. The PGI-R KO mice developed more severe pulmonary hypertension and vascular remodeling after chronic hypoxic exposure when compared to the WT mice. Our results indicate that PGI2 and its receptor play an important role in the regulation of hypoxia-induced pulmonary vascular remodeling, and that the absence of a functional receptor worsens pulmonary hypertension.

Original languageEnglish (US)
Pages (from-to)314-318
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume164
Issue number2
StatePublished - Jul 15 2001
Externally publishedYes

Fingerprint

Epoprostenol Receptors
Lung
Pulmonary Hypertension
Epoprostenol
Knockout Mice
Ventricular Pressure
Vascular Smooth Muscle
Vascular Resistance
Smooth Muscle Myocytes
Smooth Muscle
Signal Transduction
Histology
Cell Proliferation
Vascular Remodeling
Ligands

Keywords

  • Chronic hypoxia
  • Knockout mice
  • Prostacyclin receptor
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Hoshikawa, Y., Voelkel, N. F., Gesell, T. L., Moore, M. D., Morris, K. G., Alger, L. A., ... Geraci, M. W. (2001). Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. American Journal of Respiratory and Critical Care Medicine, 164(2), 314-318.

Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. / Hoshikawa, Yasushi; Voelkel, Norbert F.; Gesell, Tracy L.; Moore, Mark D.; Morris, Kenneth G.; Alger, Lori A.; Narumiya, Shuh; Geraci, Mark W.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 164, No. 2, 15.07.2001, p. 314-318.

Research output: Contribution to journalArticle

Hoshikawa, Y, Voelkel, NF, Gesell, TL, Moore, MD, Morris, KG, Alger, LA, Narumiya, S & Geraci, MW 2001, 'Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling', American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 2, pp. 314-318.
Hoshikawa Y, Voelkel NF, Gesell TL, Moore MD, Morris KG, Alger LA et al. Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. American Journal of Respiratory and Critical Care Medicine. 2001 Jul 15;164(2):314-318.
Hoshikawa, Yasushi ; Voelkel, Norbert F. ; Gesell, Tracy L. ; Moore, Mark D. ; Morris, Kenneth G. ; Alger, Lori A. ; Narumiya, Shuh ; Geraci, Mark W. / Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. In: American Journal of Respiratory and Critical Care Medicine. 2001 ; Vol. 164, No. 2. pp. 314-318.
@article{4b62f6d167a6494f8eadb4dc4834a76d,
title = "Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling",
abstract = "Prostacyclin (PGI2) reduces pulmonary vascular resistance and attenuates vascular smooth muscle cell proliferation through signal transduction following ligand binding to its receptor. Because patients with severe pulmonary hypertension have a reduced PGI2 receptor (PGI-R) expression in the remodeled pulmonary arterial smooth muscle, we hypothesized that pulmonary vascular remodeling may be modified PGI-R dependently. To test this hypothesis, PGI-R knockout (KO) and wild-type (WT) mice were subjected to a simulated altitude of 17,000 ft or Denver altitude for 3 wk, and right ventricular pressure and lung histology were assessed. The PGI-R KO mice developed more severe pulmonary hypertension and vascular remodeling after chronic hypoxic exposure when compared to the WT mice. Our results indicate that PGI2 and its receptor play an important role in the regulation of hypoxia-induced pulmonary vascular remodeling, and that the absence of a functional receptor worsens pulmonary hypertension.",
keywords = "Chronic hypoxia, Knockout mice, Prostacyclin receptor, Pulmonary hypertension",
author = "Yasushi Hoshikawa and Voelkel, {Norbert F.} and Gesell, {Tracy L.} and Moore, {Mark D.} and Morris, {Kenneth G.} and Alger, {Lori A.} and Shuh Narumiya and Geraci, {Mark W.}",
year = "2001",
month = "7",
day = "15",
language = "English (US)",
volume = "164",
pages = "314--318",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling

AU - Hoshikawa, Yasushi

AU - Voelkel, Norbert F.

AU - Gesell, Tracy L.

AU - Moore, Mark D.

AU - Morris, Kenneth G.

AU - Alger, Lori A.

AU - Narumiya, Shuh

AU - Geraci, Mark W.

PY - 2001/7/15

Y1 - 2001/7/15

N2 - Prostacyclin (PGI2) reduces pulmonary vascular resistance and attenuates vascular smooth muscle cell proliferation through signal transduction following ligand binding to its receptor. Because patients with severe pulmonary hypertension have a reduced PGI2 receptor (PGI-R) expression in the remodeled pulmonary arterial smooth muscle, we hypothesized that pulmonary vascular remodeling may be modified PGI-R dependently. To test this hypothesis, PGI-R knockout (KO) and wild-type (WT) mice were subjected to a simulated altitude of 17,000 ft or Denver altitude for 3 wk, and right ventricular pressure and lung histology were assessed. The PGI-R KO mice developed more severe pulmonary hypertension and vascular remodeling after chronic hypoxic exposure when compared to the WT mice. Our results indicate that PGI2 and its receptor play an important role in the regulation of hypoxia-induced pulmonary vascular remodeling, and that the absence of a functional receptor worsens pulmonary hypertension.

AB - Prostacyclin (PGI2) reduces pulmonary vascular resistance and attenuates vascular smooth muscle cell proliferation through signal transduction following ligand binding to its receptor. Because patients with severe pulmonary hypertension have a reduced PGI2 receptor (PGI-R) expression in the remodeled pulmonary arterial smooth muscle, we hypothesized that pulmonary vascular remodeling may be modified PGI-R dependently. To test this hypothesis, PGI-R knockout (KO) and wild-type (WT) mice were subjected to a simulated altitude of 17,000 ft or Denver altitude for 3 wk, and right ventricular pressure and lung histology were assessed. The PGI-R KO mice developed more severe pulmonary hypertension and vascular remodeling after chronic hypoxic exposure when compared to the WT mice. Our results indicate that PGI2 and its receptor play an important role in the regulation of hypoxia-induced pulmonary vascular remodeling, and that the absence of a functional receptor worsens pulmonary hypertension.

KW - Chronic hypoxia

KW - Knockout mice

KW - Prostacyclin receptor

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=0035880165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035880165&partnerID=8YFLogxK

M3 - Article

C2 - 11463607

AN - SCOPUS:0035880165

VL - 164

SP - 314

EP - 318

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -